.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J06B_Immunoglobulins.J06BB13_PertussisImmunoglobulin.PertussisImmunoglobulin .Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J06B_Immunoglobulins.J06BB13_PertussisImmunoglobulin.PertussisImmunoglobulin| name: | PertussisImmunoglobulin |
| ATC code: | J06BB13 | route: | intramuscular |
| n-compartments | 1 |
Pertussis immunoglobulin is a human-derived immunoglobulin product that provides passive immunity against Bordetella pertussis, the bacterium responsible for whooping cough. It has been investigated and used previously as a prophylactic and therapeutic option mainly in high-risk infants or immunocompromised individuals, though it is not in widespread approved use today due to limited evidence and the efficacy of vaccination.
No specific pharmacokinetic studies or publications reporting detailed model parameters for pertussis immunoglobulin in humans could be found.